NGM
Ngm Biopharmaceuticals Inc

1,273
Loading...
Loading...
NGM Biopharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel biologic drug candidates. Its programs include NGM707 and pembrolizumab for treating metastatic solid tumors, Aldafermin for primary sclerosing cholangitis, and NGM120 for hyperemesis gravidarum. The company was founded by Jin Long Chen on December 20, 2007 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
138

Frequently Asked Questions

What is Market Cap of Ngm Biopharmaceuticals Inc?
What is the 52-week high for Ngm Biopharmaceuticals Inc?
What is the 52-week low for Ngm Biopharmaceuticals Inc?
What is Ngm Biopharmaceuticals Inc stock price today?
What was Ngm Biopharmaceuticals Inc stock price yesterday?
What is the PE ratio of Ngm Biopharmaceuticals Inc?
What is the Price-to-Book ratio of Ngm Biopharmaceuticals Inc?
What is Ngm Biopharmaceuticals Inc's EBITDA?
What is the 50-day moving average of Ngm Biopharmaceuticals Inc?
How many employess does Ngm Biopharmaceuticals Inc has?

Latest NGM News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.